Showing results (921-930 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|September 24, 2021
Short-Term Safety of Repeated Acetaminophen Use in Patients With Compensated CirrhosisMitchell R McGill, Laura P James, Sandra S McCullough, et al.
Hepatology Communications|September 24, 2021
WNT7B Regulates Cholangiocyte Proliferation and Function During Murine CholestasisKaris Kosar, Pamela Cornuet, Sucha Singh, et al.
Hepatology Communications|September 24, 2021
Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver DiseaseAshwini Arvind, Jacqueline B Henson, Stephanie A Osganian, et al.
Hepatology Communications|September 24, 2021
Clinical Staging of Mass-Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance ImagingYeun-Yoon Kim, Suk-Keu Yeom, Hyejung Shin, et al.
Hepatology Communications|September 24, 2021
Wilson's Disease: An Analysis of Health Care Use and Cost Burden of Commercially Insured Adults in the United StatesVinod K Rustgi, Kapil Gupta, Christopher Tait, et al.
Hepatology Communications|February 8, 2022
Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990-2019Seyyed-Hadi Ghamari, Moein Yoosefi, Mohsen Abbasi-Kangevari, et al.
Hepatology Communications|October 22, 2021
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C VirusNobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
Hepatology Communications|February 11, 2022
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver DiseaseGrazia Pennisi, Rosaria Maria Pipitone, Marco Enea, et al.
Hepatology Communications|February 11, 2022
Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer-BioNTech COVID-19 Vaccine in Medical EmployeesAsher Shafrir, Johnny Amer, David Hakimian, et al.
Pageof 179